MedTrace Logo

Effect of Hericium Erinaceus on Clinical Patients With Hearing Impairment

NCT03632512 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2018-08-15

No results posted yet for this study

Summary

This study aims to investigate the effect of Hericium Erinaceus on clinical patients with hearing impairment and possible mechanisms. Subjects with hearing impairment will be enrolled and randomly divided into experimental or control group supplemented with Hericium Erinaceus (430 mg/kg/day) or placebo, respectively for eight months. Basic characteristics will be evaluated at baseline by questionnaire. The hearing, liver and kidney functions, and neurotrophic factors will be examined at baseline, 4th month and 8th month.

Conditions

  • Tinnitus

Interventions

DIETARY_SUPPLEMENT

Hericium honey bolus

The subjects of the experimental group will be supplemented with Hericium Erinaceus honey bolus(430 mg/kg/day) for eight months.

DIETARY_SUPPLEMENT

Placebo honey bolus

The subjects of the control group will be supplemented with Placebo honey bolus(8 bolus/ day) for 8 months.

Sponsors & Collaborators

  • Providence University, Taiwan

    lead OTHER

Principal Investigators

  • Yin-Ching Chan · Providence University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-18
Primary Completion
2019-01-17
Completion
2020-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03632512 on ClinicalTrials.gov